Y Intercept (Hong Kong) LTD Organogenesis Holdings Inc. Transaction History

Y Intercept (Hong Kong) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.9 - $4.3 $42,932 - $97,162	22,596 New	22,596 $75,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $3.43 $60,514 - $83,695	-24,401 Closed	0 $0
Q3 2022 Feb 14, 2023	SELL	$3.14 - $6.43 $24,862 - $50,912	-7,918 Reduced 24.5%	24,401 $79,000
Q2 2022 Aug 08, 2022	BUY	$4.74 - $8.15 $153,192 - $263,399	32,319 New	32,319 $158,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.